Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab

Condition:   Multiple Sclerosis Intervention:   Biological: COVID-19 vaccination Sponsors:   Sheba Medical Center;   Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials